|
| Exchange Disseminated Time | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 9, 2016, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2015 (Q3).
Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated Persons of the Company from February 2, 2016 to February 11, 2016 (both days inclusive). |
|
|